Acta Scientific Microbiology (ASMI) (ISSN: 2581-3226)

Compressive Review Volume 3 Issue 5

A Complete Overview and Guidelines for nCOv-2019 (COVID-19) with Special Reference to Corporate Hospital

Avinash Teli1*, Azaz Ahmad1, Danish Azad2, Mohd Ajmal2, Shaziya Sheikh3 and Arvind Kumar3

1Department of Clinical Pharmacology, Nayati Medicity, Mathura, Uttar Pradesh, India
2Department of Clinical Pharmacology, Eternal Hospital, Jaipur, Rajasthan, India
2Departement of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
3Outreach Department, Nayati Medicity, Mathura, Uttar Pradesh, India
3Department of Quality, Sarvodaya Hospital, Faridabad, Haryana, India

*Corresponding Author: Avinash Teli, Head of Clinical Pharmacology, Nayati Medicity, Mathura, Uttar Pradesh, India.

Received: March 23, 2020; Published: April 17, 2020



  An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention. On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 epidemic as a public health emergency of international concern. Meanwhile, several independent research groups have identified that SARS-CoV-2 belongs to β-coronavirus, with highly identical genome to bat coronavirus, pointing to bat as the natural host. These policies included large-scale quarantine, strict controls on travel and extensive monitoring of suspected cases. However, it is unknown whether these policies have had an impact on the epidemic. We sought to show how these control measures impacted the containment of the epidemic. The novel coronavirus uses the same receptor, angiotensin- converting enzyme 2 (ACE2) as that for SARS-CoV and mainly spreads through the respiratory tract. Importantly, increasingly evidence showed sustained human-to-human transmission, along with many exported cases across the globe. The clinical symptoms of COVID-19 patients include fever, cough, fatigue and a small population of patients appeared gastrointestinal infection symptoms

Keywords: COVID-19; nCOv-2019; Corona Virus; Respiratory Depression; Corporate Hospital; Guidelines; Hand Hygiene; Pandemic



Citation: Avinash Teli., et al. “A Complete Overview and Guidelines for nCOv-2019 (COVID-19) with Special Reference to Corporate Hospital". Acta Scientific Microbiology 3.5 (2020): 81-96.


Acceptance rate30%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US